East China Normal University and Aurisco Pharmaceutical Co., Ltd. jointly inaugurated AI-Driven Oligonucleotide Drugs Discovery Laboratory. The signing and inauguration ceremony of the AI-Driven Oligonucleotide Drugs Discovery Joint Laboratory was held at East China Normal University's Putuo Campus.
Aurisco achieved a score of 78 in the 2024 EcoVadis Corporate Social Responsibility Rating and was awarded a GOLD medal by EcoVadis.
Aurisco's first oligonucleotide commercial manufacturing line was successfully delivered by Cytiva, accelerating the commercialization process of oligonucleotide drugs.
Aurisco will participate in the CPHI exhibition in Milan, Italy, on October 8-10, 2024, exhibition number Hall1B50.
Aurisco will Exhibit at CPHI China 19-21 June 2024. Shanghai New International Expo Center. #booth at W2C02 #